Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1997-98 influenza season (superseding MMWR 1996;45[No. RR-5]:1-24). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1997-98, b) the vaccination of pregnant and breastfeeding women, and c) side effects and adverse reactions.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003428:Cross Infection / Q000517:prevention & control; D005260:Female; D015658:HIV Infections; D006801:Humans; D007223:Infant; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D008875:Middle Aged; D011247:Pregnancy; D012299:Rimantadine / Q000627:therapeutic use*; D012307:Risk Factors; D014195:Travel; D014481:United States; D014611:Vaccination / Q000592:standards*; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects
D000998:Antiviral Agents; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D012299:Rimantadine; D000547:Amantadine